Australian experts welcome a new global definition of heart attack, which they say will make it easier to diagnose women.
The updated guidelines group coronary events more common in women alongside the main type of heart attacks and recommend sex-specific diagnostic blood test thresholds.
Although these new guidelines will help improve diagnosis, experts say there are some gender gaps relating to cardiac treatment that still need to be addressed.
Nadene Hall had never heard of a spontaneous coronary artery dissection (SCAD) heart attack until she had one.
It was 7:30am on March 25, 2023, and Ms Hall was finishing up a strength-based session at the gym when she felt a cramp across her chest.
"As I was walking downstairs to the car park, I started to feel a bit hot, like clammy, and my left hand started to feel a bit tingly," she said.
Ms Hall went home feeling nauseated, vomited and then called an ambulance.
Ms Hall was diagnosed with SCAD, a type of heart attack caused by a tear in a coronary artery that mainly affects women with few traditional risk factors.
An Australian study suggests that nearly one in four acute coronary syndrome events in women under the age of 60 were caused by SCAD.
But the condition can be easy to misdiagnose and is sometimes associated with menopause, stress or childbirth.
Experts said a new global definition of heart attack, published recently in the European Heart Journal, would help improve the diagnosis of women like Ms Hall and lead to better outcomes.
The new definition separates heart attacks into three categories depending on how the patient presented clinically:
Baker Heart and Diabetes Institute professorial research fellow Tom Marwick said the "good update" considered the underlying cause of a heart attack and made it easier to communicate to patients.
Heart Foundation head of clinical strategy Natalie Raffoul said the update would improve heart attack diagnosis in women for two reasons.
Firstly, she said, the global guidelines included a recommendation for sex-specific troponin ranges.
When the heart is damaged or inflamed, it releases proteins called troponin into the bloodstream, which doctors can test for.
But troponin levels differ between men and women.
Ms Raffoul said sex-specific ranges would help doctors do a "better job at picking up heart attacks in women when they're presenting with symptoms".
The second change Ms Raffoul said was that coronary events more common in women, such as SCAD, were now grouped with the main type of heart attacks.
"That's a great thing because that means when a woman comes to the emergency room, presenting with heart attack symptoms, clinicians can consider less common coronary events such as SCAD," she said.
Ms Raffoul said the global guidelines were closely aligned with the Heart Foundation's clinical guidelines for diagnosing and managing acute coronary syndromes in Australia.
Cardiovascular disease is one of the leading causes of death for Australian women.
Ms Raffoul said although chest pain or pressure were the most common symptoms of a heart attack in men and women, there could be some differences between the sexes.
"Women are more likely than men to experience non-chest pain symptoms," Ms Raffoul said.
A 2025 study found Australian women having a heart attack were less likely to be promptly diagnosed and treated compared to men.
Ms Raffoul said although the new guidelines would help clinicians detect and diagnose heart attacks in women, there was still a "significant treatment gap for women".
"Less likely to receive that stent or ballooning within a certain time frame, less likely to receive preventive medicines after diagnosis and also less likely to be referred to, and attend, cardiac rehab.
Ms Raffoul said many updates in the global guidelines, including sex-specific troponin blood test thresholds and an emphasis on cardiac events more common in women, such as SCAD, were already included in the Heart Foundation's guidelines, putting Australia on the "front foot".
But Julie Redfern, a Bond University professor of public health who contributed to Australia's guidelines, said some women were still "falling through the cracks" and not being diagnosed or treated in a timely fashion.
"We need better adherence [to the guidelines]," she said.
Professor Redfern, who specialises in heart attack survivorship, said this meant providing the best possible treatment for each patient based on factors like the type of heart attack they experienced, not offering a "one-size-fits-all" approach to cardiovascular disease.
Ms Raffoul and Professor Redfern hoped the new global guidelines would encourage clinicians in Australia to learn more about heart attack causes and symptoms for women.
Ms Hall wants women — especially healthy, young women like herself — to know the warning signs and reach out for help.
"We always put everyone else first. Sometimes we have to put ourselves first and get checked out."